Thomas Rogers

Prof. Thomas Rogers


Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2003 in Journal of Leukocyte Biology
Verified
Journal Article
Open access
PDF file
ISImre Szabo
Imre Szabo
MWMichele A Wetzel
Michele A Wetzel
NZNing Zhang
Ning Zhang
ASAmber D. Steele
Amber D. Steele
DKDavid E Kaminsky
David E Kaminsky
TRThomas Rogers
Thomas Rogers
The opiates are well-established immunomodulatory factors, and recent evidence suggests that μ- and δ-opioid receptor ligands alter chemokine-driven chemotactic responses through the process of heterologous desensitization. In the present report, we sought to examine the capacity of μ- and δ-opioids to modulate the function of chemokine receptors CCR5 and CXCR4, the two major human immunodeficiency virus (HIV) coreceptors. We found that the chemotactic responses to the CCR1/5 ligand CCL5/regulated on activation, normal T expressed and secreted, but not the CXCR4 ligand stromal cell-derived factor-1α/CXCL12 were inhibited following opioid pretreatment. Studies were performed with primary monocytes and Chinese hamster ovary cells transfected with CCR5 and the μ-opioid receptor to determine whether cross-desensitization of CCR5 was a result of receptor internalization. Using radiolabeled-binding analysis, flow cytometry, and confocal microscopy, we found that the heterologous desensitization of CCR5 was not associated with a significant degree of receptor internalization. Despite this, we found that the cross-desensitization of CCR5 by opioids was associated with a decrease in susceptibility to R5 but not X4 strains of HIV-1. Our findings are consistent with the notion that impairment of the normal signaling activity of CCR5 inhibits HIV-1 coreceptor function. These results have significant implications for our understanding of the effect of opioids on the regulation of leukocyte trafficking in inflammatory disease states and the process of coreceptor-dependent HIV-1 infection. The interference with HIV-1 uptake by heterologous desensitization of CCR5 suggests that HIV-1 interaction with this receptor is not passive but involves a signal transduction process.

1 July 2017 in Cancer Research
Verified
Journal Article
Open access
PDF file
VBValerie N. Barton
Valerie N. Barton
Jessica L. ChristensonJessica L. Christenson
Jessica L. Christenson
MGMichael A. Gordon
Michael A. Gordon
LGLisa I. Greene
Lisa I. Greene
TRThomas Rogers
Thomas Rogers
JRJennifer K. Richer
Jennifer K. Richer
Preclinical and early clinical trials indicate that up to 50% of triple-negative breast cancers (TNBC) express androgen receptor (AR) and are potentially responsive to antiandrogens. However, the function of AR in TNBC and the mechanisms by which AR-targeted therapy reduces tumor burden are largely unknown. We hypothesized that AR maintains a cancer stem cell (CSC)-like tumor-initiating population and serves as an antiapoptotic factor, facilitating anchorage independence and metastasis. AR levels increased in TNBC cells grown in forced suspension culture compared with those in attached conditions, and cells that expressed AR resisted detachment-induced apoptosis. Culturing TNBC cells in suspension increased the CSC-like population, an effect reversed by AR inhibition. Pretreatment with enzalutamide (Enza) decreased the tumor-initiating capacity of TNBC cells and reduced tumor volume and viability when administered simultaneously or subsequent to the chemotherapeutic paclitaxel; simultaneous treatment more effectively suppressed tumor recurrence. Overall, our findings suggest that AR-targeted therapies may enhance the efficacy of chemotherapy even in TNBCs with low AR expression by targeting a CSC-like cell population with anchorage independence and invasive potential. Cancer Res; 77(13); 3455–66. ©2017 AACR.

1 July 2008 in Journal of Neuroimmunology
Verified
Journal Article
Closed access
MFMatthew J. Finley
Matthew J. Finley
XCXiaohong Chen
Xiaohong Chen
GBGuiseppe Bardi
Guiseppe Bardi
PDPenny Davey
Penny Davey
EGEllen B. Geller
Ellen B. Geller
TRThomas Rogers
Thomas Rogers

1 December 2013 in Journal of Neuroimmunology
Verified
Journal Article
Closed access
WCWilliam D. Cornwell
William D. Cornwell
MLMark G. Lewis
Mark G. Lewis
XFXiaoxuan Fan
Xiaoxuan Fan
JRJay Rappaport
Jay Rappaport
TRThomas Rogers
Thomas Rogers

15 June 2018 in BMC Pulmonary Medicine
Verified
Journal Article
Open access
PDF file
WCWilliam D. Cornwell
William D. Cornwell
VKVictor Kim
Victor Kim
XFXiaoxuan Fan
Xiaoxuan Fan
MVMarie Elena Vega
Marie Elena Vega
FRFrederick V. Ramsey
Frederick V. Ramsey
TRThomas Rogers
Thomas Rogers
The ability of circulating monocytes to develop into lung macrophages and promote lung tissue damage depends upon their phenotypic pattern of differentiation and activation. Whether this phenotypic pattern varies with COPD severity is unknown. Here we characterize the activation and differentiation status of circulating monocytes in patients with moderate vs. severe COPD. Blood monocytes were isolated from normal non-smokers (14), current smokers (13), patients with moderate (9), and severe COPD (11). These cells were subjected to analysis by flow cytometry to characterize the expression of activation markers, chemoattractant receptors, and surface markers characteristic of either M1- or M2-type macrophages. Patients with severe COPD had increased numbers of total circulating monocytes and non-classical patrolling monocytes, compared to normal subjects and patients with moderate COPD. In addition, while the percentage of circulating monocytes that expressed an M2-like phenotype was reduced in patients with either moderate or severe disease, the levels of expression of M2 markers on this subpopulation of monocytes in severe COPD was significantly elevated. This was particularly evident for the expression of the chemoattractant receptor CCR5. Blood monocytes in severe COPD patients undergo unexpected pre-differentiation that is largely characteristic of M2-macrophage polarization, leading to the emergence of an unusual M2-like monocyte population with very high levels of CCR5. These results show that circulating monocytes in patients with severe COPD possess a cellular phenotype which may permit greater mobilization to the lung, with a pre-existing bias toward a potentially destructive inflammatory phenotype.

31 May 1997 in Journal of Neuroimmunology
Verified
Journal Article
Closed access
PDF file
LGLiming Guan
Liming Guan
TEToby K Eisenstein
Toby K Eisenstein
MAMartin W Adler
Martin W Adler
TRThomas Rogers
Thomas Rogers